By Dennis Thompson HealthDay ReporterWEDNESDAY, June 3, 2026 (HealthDay News) — A recently approved cancer immunotherapy can put nearly two-thirds of people with relapsed multiple myeloma into ...
Throughout his longstanding career in the music industry, Macklemore has been open about his struggles with addiction and the obstacles he's faced on his path to sobriety. Sprinkled throughout his ...
Tecvayli plus Darzalex Faspro improved overall and progression-free survival in relapsed/refractory multiple myeloma compared to standard treatments. Tec-Dara showed a higher complete response rate ...
Multiple myeloma is considered to be relapsed if symptoms of the disease appear after a time of improvement. It’s considered to be refractory when it gets worse even though it’s being treated. To ...
Evaluation of prophylactic tocilizumab (toci) for the reduction of cytokine release syndrome (CRS) to inform the management of patients (pts) treated with teclistamab in MajesTEC-1. This is an ASCO ...